Bronchoalveolar lavage fluid from symptomatic asthmatics contains elevated levels of several proinflammatory interleukins including interleukin-1β (IL-1β). Biologic activities of IL-1β are considered to be critical in the inflammatory process. Since these characteristics include mitogenic properties, we investigated the effect of IL-1β on the proliferation of airway smooth muscle (ASM) cells isolated from guinea pig tracheas. Primary tissue culture of ASM cells was maintained in media containing 0%, 1%, or 10% fetal bovine serum (FBS). Cultures were exposed up to 6 days to a human recombinant IL-1β (20, 40, or 100 pg/ml) in the presence or absence of indomethacin. The proliferation of ASM cells was assessed with two techniques: a direct counting of cells with a hemocytometer and/or with a [3H]-thymidine incorporation, an established marker of DNA synthesis. The evaluation was done daily, up to the sixth day after exposure of cells to different doses of IL-1β. We found that the exposure of ASM cells to human recombinant IL-1β significantly (P < 0.01) increased the number of tracheal myocytes as well as the [3H]-thymidine incorporation into ASM cells. These changes were dependent upon the dose of IL-1β and the concentration of FBS in the cultured medium. The most active proliferation of ASM cells was observed in medium containing 1% FBS, indomethacin (1 µg/ml), and IL-1β (100 pg/ml). The presence of indomethacin in the culture medium was essential to demonstrate the proliferative effect of IL-1β. Pretreatment with specific polyclonal antibodies against platelet-derived growth factor (PDGF-BB homodimer) completely inhibited the IL-1β-induced increase in [3H]-thymidine incorporation by ASM cells. In contrast, the presence of human recombinant PDGF-BB (1.5 ng/ml) in the incubation medium further potentiated the ASM proliferation induced by IL-1β. This potentiation of proliferation was also dose-dependent: PDGF-BB (1.5 and 2.5 ng/ml) alone potentiated (P < 0.01) proliferation of ASM cells. It can be concluded that proinflammatory cytokine, such as IL-1β which is produced in asthma, stimulates proliferation of ASM cells through the PDGF-dependent mechanism. This effect may be critically important in an increase of ASM cell mass observed in asthma.
No takes yet. Share an insight, caveat, or question.
De et al. (1993) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: